Ngā hua rapu - Allan D. Sniderman
- E whakaatu ana i te 1 - 20 hua o te 64
- Haere ki te Whārangi Whai Ake
-
1
Substrate delivery as a determinant of hepatic apoB secretion. mā Allan D. Sniderman, Katherine Cianflone
I whakaputaina 1993Revisão -
2
The Severe Hypercholesterolemia Phenotype mā Allan D. Sniderman, Sotirios Tsimikas, Sergio Fazio
I whakaputaina 2014Revisão -
3
-
4
-
5
-
6
Determination of B protein of low density lipoprotein directly in plasma. mā Allan D. Sniderman, Bunyen Teng, M Jerry
I whakaputaina 1975Artigo -
7
-
8
-
9
-
10
-
11
-
12
-
13
Low Density Lipoprotein mā Allan D. Sniderman, David W. Thomas, D Marpole, Ba‐Bie Teng
I whakaputaina 1978Artigo -
14
Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hyperc... mā Bunyen Teng, Allan D. Sniderman, Anne K. Soutar, Gilbert R. Thompson
I whakaputaina 1986Artigo -
15
-
16
-
17
-
18
Apoproteins B and A-I and coronary artery disease in humans. mā J. D. Brunzell, Allan D. Sniderman, J J Albers, Peter O. Kwiterovich
I whakaputaina 1984Revisão -
19
-
20
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Cholesterol
Endocrinology
Apolipoprotein B
Lipoprotein
Biology
Chemistry
Disease
Biochemistry
Cardiology
Very low-density lipoprotein
High-density lipoprotein
Low-density lipoprotein
Triglyceride
Confidence interval
Environmental health
Diabetes mellitus
Population
Statin
Adipose tissue
Fatty acid
Hazard ratio
Insulin
Intensive care medicine
Obesity
Risk factor
Coronary artery disease
Framingham Risk Score
Genetics